Encorafenib/Cetuximab Plus FOLFIRI Prolongs PFS Over SOC in BRAF V600E–Mutant mCRC Read More » March 4, 2026
FDA Grants Full Approval to Encorafenib Plus Cetuximab/Chemotherapy for BRAF V600E+ mCRC Read More » March 4, 2026
FDA Grants Fast Track Status to NG-350A for pMMR Locally Advanced Rectal Cancer Read More » October 16, 2025
World-first trial highlights survival benefits of exercise for colon cancer Read More » July 28, 2025
New Long term results from CHECKMATE-8HW trial for metastatic colorectal cancer Read More » July 28, 2025
COLLISION trial analysis suggests new standard of care for small-size colorectal liver metastases Read More » March 17, 2025
Aspirin May Reduce Risk of Colorectal Cancer Recurrence for Some Patients Read More » February 17, 2025